Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Expansion of a novel endogenous retrovirus throughout the pericentromeres of modern humans.

Zahn J, Kaplan MH, Fischer S, Dai M, Meng F, Saha AK, Cervantes P, Chan SM, Dube D, Omenn GS, Markovitz DM, Contreras-Galindo R.

Genome Biol. 2015 Apr 12;16(1):74. [Epub ahead of print]

PMID:
25886262
2.

Genomic flexibility of human endogenous retrovirus type K.

Dube D, Contreras-Galindo R, He S, King SR, Gonzalez-Hernandez MJ, Gitlin SD, Kaplan MH, Markovitz DM.

J Virol. 2014 Sep 1;88(17):9673-82. doi: 10.1128/JVI.01147-14. Epub 2014 Jun 11.

3.

Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Gonzalez-Hernandez MJ, Cavalcoli JD, Sartor MA, Contreras-Galindo R, Meng F, Dai M, Dube D, Saha AK, Gitlin SD, Omenn GS, Kaplan MH, Markovitz DM.

J Virol. 2014 Aug;88(16):8924-35. doi: 10.1128/JVI.00556-14. Epub 2014 May 28.

4.

HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses.

Contreras-Galindo R, Kaplan MH, He S, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Kappes F, Dube D, Chan SM, Robinson D, Meng F, Dai M, Gitlin SD, Chinnaiyan AM, Omenn GS, Markovitz DM.

Genome Res. 2013 Sep;23(9):1505-13. doi: 10.1101/gr.144303.112. Epub 2013 May 8.

5.

Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.

Monde K, Contreras-Galindo R, Kaplan MH, Markovitz DM, Ono A.

J Virol. 2012 Oct;86(20):11194-208. Epub 2012 Aug 1.

6.

Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ Jr, Kaplan MH, Markovitz DM.

J Virol. 2012 Aug;86(15):7790-805. doi: 10.1128/JVI.07215-11. Epub 2012 May 16.

7.

Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.

Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM.

J Virol. 2012 Jan;86(1):262-76. doi: 10.1128/JVI.00602-11. Epub 2011 Oct 26.

8.

NGSQC: cross-platform quality analysis pipeline for deep sequencing data.

Dai M, Thompson RC, Maher C, Contreras-Galindo R, Kaplan MH, Markovitz DM, Omenn G, Meng F.

BMC Genomics. 2010 Dec 2;11 Suppl 4:S7. doi: 10.1186/1471-2164-11-S4-S7.

9.

Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.

Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD, Markovitz DM.

J Virol. 2008 Oct;82(19):9329-36. doi: 10.1128/JVI.00646-08. Epub 2008 Jul 16.

10.

Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy.

Contreras-Galindo R, Almodóvar-Camacho S, González-Ramírez S, Lorenzo E, Yamamura Y.

AIDS Res Hum Retroviruses. 2007 Sep;23(9):1083-6.

PMID:
17919102
11.

HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro.

Contreras-Galindo R, López P, Vélez R, Yamamura Y.

AIDS Res Hum Retroviruses. 2007 Jan;23(1):116-22.

PMID:
17263641
12.

Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.

Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y.

AIDS Res Hum Retroviruses. 2006 Oct;22(10):979-84.

PMID:
17067267
13.

A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens.

Contreras-Galindo R, González M, Almodovar-Camacho S, González-Ramírez S, Lorenzo E, Yamamura Y.

J Virol Methods. 2006 Sep;136(1-2):51-7. Epub 2006 May 6.

PMID:
16678919
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk